A Comprehensive Review of Hepatitis
Keywords:
viral hepatitis, gender differences in immunity, liver diseaseAbstract
Background: Viral hepatitis remains a major public health concern in Iraq, particularly in regions with limited healthcare infrastructure. Despite global progress in prevention and treatment, hepatitis continues to cause significant morbidity and mortality. To better understand its epidemiological profile, we conducted a regional study in Al-Diwaniyah Governorate.
References
- Pawlotsky JM. Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens. Gastroenterology. 2016;151(1):70-86.
-Heidrich B, Yurdaydin C, Kabaçam G, Manns MP. Treatment of hepatitis delta virus infection. Antivir Ther. 2020;25(3):73-80.
-Himoto T, Masaki T. Nutritional management of chronic liver diseases. Nutrients. 2019;11(5):1056.
-Smith PJ, et al. Global strategies to eliminate Hepatitis B by 2030. Int J Public Health. 2023;50(6):723-34.
-Tanaka Y, et al. Immunogenicity of Hepatitis B vaccines in older adults and special populations. Liver Int. 2020;40(8):1887-95.
-Walker CM, Grakoui A. Hepatitis C virus vaccine research: Progress and challenges. Nat Rev Gastroenterol Hepatol. 2021;18(9):688-700.
- Seto WK, Lo YR, Pawlotsky JM, Yuen MF. Chronic hepatitis B virus infection. Lancet. 2018;392(10161):2313-24.
- Costa JD. Development of a therapeutic hepatitis B vaccine: Designing a particulate-based multicomponent prototype for immunomodulation. BAES Repository. 2024.
- Andrade RJ, Chalasani N. Drug-induced liver injury: A systematic review. J Hepatol. 2015;63(5):1238-54.
- Asselah T, Marcellin P. Direct-acting antivirals for the treatment of chronic hepatitis C: One pill a day for tomorrow. Liver Int. 2016;36(Suppl 1):74-81.
-Flanagan, K. L. & Jensen, K. J. in Sex and Gender Differences in Infection and Treatments for Infectious Diseases (eds Klein, S. L. & Roberts, C. W.) 273–312 (Springer, 2015).
-Vom Steeg, L. G. & Klein, S. L. SeXX Matters in infectious disease pathogenesis. PLoS Pathog. 12, e1005374 (2016).
-Nelson NP, Weng MK, Hofmeister MG, Moore KL, Doshani M, Kamili S, et al. Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep 2020;69:1–38.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Al-Qadisiyah Journal for Biomedical and Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
